-
EP2465580
European procedure
Extract from the Register of European Patents
EP About this file: EP2465580
| EP2465580 - Polycyclic carbamoylpyridone derivatives having hiv integrase inhibitory activity [Right-click to bookmark this link] | Status | No opposition filed within time limit Status updated on 24.10.2014 Database last updated on 01.04.2026 | Most recent event Tooltip | 24.04.2015 | Change - lapse in a contracting state State(s) deleted from list of lapses: RO | published on 27.05.2015 [2015/22] | Applicant(s) | For all designated states VIIV Healthcare Company Five Moore Drive Research Triangle Park, NC 27709 / US | For all designated states Shionogi & Co., Ltd. 1-8, Doshomachi 3-chome Chuo-ku Osaka-shi Osaka 541-0045 / JP | [N/P] |
| Former [2013/33] | For all designated states VIIV Healthcare Company Five Moore Drive Research Triangle Park, NC 27709 / US | ||
| For all designated states Shionogi & Co., Ltd. 1-8, Doshomachi 3-chome Chuo-ku Osaka-shi Osaka 541-0045 / JP | |||
| Former [2012/25] | For all designated states Glaxosmithkline LLC One Franklin Plaza 200 North 16th Street Philadelphia, PA 19102 / US | ||
| For all designated states Shionogi & Co., Ltd. 1-8, Doshomachi 3-chome Chuo-ku Osaka-shi Osaka 541-0045 / JP | Inventor(s) | 01 /
Johns, Brian Alvin GlaxosmithKline Five Moore Drive P O Box 13398 Research Triangle Park, NC North Carolina 2770 9 / US | 02 /
Kawasuji, Takashi Shionogi & Co,. Ltd 12-4, Sagisu 5-chome Fukushima-ku, Osaka 553-0002 / JP | 03 /
Taishi, Teruhiko Shionogi & Co., Ltd 12-4, Sagisu 5-chome Fukushima-ku, Osaka 553-0002 / JP | 04 /
Taoda, Yoshiyuki Shionogi & Co., Ltd 12-4, Sagisu 5-chome Fukushima-ku, Osaka 553-0002 / JP | [2012/25] | Representative(s) | Keen, Celia Mary J A Kemp 14 South Square Gray's Inn London WC1R 5JJ / GB | [2012/25] | Application number, filing date | 12159082.2 | 28.04.2006 | [2012/25] | Priority number, date | JP20050131161 | 28.04.2005 Original published format: JP 2005131161 | JP20050312076 | 27.10.2005 Original published format: JP 2005312076 | [2012/25] | Filing language | EN | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | EP2465580 | Date: | 20.06.2012 | Language: | EN | [2012/25] | Type: | B1 Patent specification | No.: | EP2465580 | Date: | 18.12.2013 | Language: | EN | [2013/51] | Search report(s) | (Supplementary) European search report - dispatched on: | EP | 03.05.2012 | Classification | IPC: | A61P31/18, A61K31/4985, C07D498/04 | [2012/25] | CPC: |
C07D498/14 (EP,US);
C07D471/14 (EP,NO,US);
A61K31/4985 (EP,KR,NO,US);
A61K31/519 (EP,US);
A61K31/5365 (EP,US);
A61K31/551 (EP,US);
A61K45/06 (US);
A61K9/0053 (US);
A61K9/20 (EP);
A61P31/00 (EP);
A61P31/12 (EP);
A61P31/18 (EP);
A61P37/02 (EP);
A61P43/00 (EP);
C07D471/04 (EP,US);
C07D471/22 (EP,US);
C07D498/04 (EP,NO,US);
C07D498/20 (EP,US);
C07D498/22 (EP,US)
(-)
| Designated contracting states | AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HU, IE, IS, IT, LI, LT, LU, LV, MC, NL, PL, PT, RO, SE, SI, SK, TR [2012/25] | Title | German: | Polyzyklisches Carbamoylpyridon-Derivate mit HIV-integrasehemmender Aktivität | [2012/25] | English: | Polycyclic carbamoylpyridone derivatives having hiv integrase inhibitory activity | [2012/25] | French: | Dérivés de carbamoylpyridone polycyclique dotés d'une activité inhibitrice de l'intégrase du VIH | [2012/25] | Examination procedure | 18.06.2012 | Amendment by applicant (claims and/or description) | 18.06.2012 | Examination requested [2012/31] | 27.08.2012 | Despatch of a communication from the examining division (Time limit: M04) | 11.12.2012 | Reply to a communication from the examining division | 20.02.2013 | Communication of intention to grant the patent | 17.05.2013 | Disapproval of the communication of intention to grant the patent by the applicant or resumption of examination proceedings by the EPO | 27.06.2013 | Communication of intention to grant the patent | 07.11.2013 | Fee for grant paid | 07.11.2013 | Fee for publishing/printing paid | Parent application(s) Tooltip | EP06758843.4 / EP1874117 | Divisional application(s) | The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued (EP20060758843) is 03.03.2010 | Opposition(s) | 19.09.2014 | No opposition filed within time limit [2014/48] | Fees paid | Renewal fee | 12.03.2012 | Renewal fee patent year 03 | 12.03.2012 | Renewal fee patent year 04 | 12.03.2012 | Renewal fee patent year 05 | 12.03.2012 | Renewal fee patent year 06 | 12.03.2012 | Renewal fee patent year 07 | 12.04.2013 | Renewal fee patent year 08 |
| Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
| Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Lapses during opposition Tooltip | deleted | [2015/22] |
| Former [2014/37] | RO | 18.12.2013 | Documents cited: | Search | [A] US2005054645 (MIYAZAKI SUSUMU et al.) | [A] WO2004058757 (ANGELETTI P IST RICHERCHE BIO et al.) | by applicant | WO03016275 | WO2004024693 | WO03035076 | WO2004004657 | JP2003032772 | JPH02108668 | JPH02108683 | JPH0296506 | WO2005016927 | JARMY G. ET AL., J. MEDICAL VIROLOGY, vol. 64, 2001, pages 223 - 231 |